Ben Hwang discusses innovative diagnostic real-time monitoring data-sensors

Ben Hwang, MA, PhD, Chairman and CEO of Profusa, a company innovating in diagnostics and real-time disease monitoring, talks to us about how continuous data sensors could transform the way we monitor patients’ disease progression and treatment efficacy. Ben shows us the device that Profusa have developed, which can be placed inside the body to monitor molecular changes in the blood over a year or more. This means that instead of visiting a clinic, a patient can be monitored in real-time, from anywhere. This could mean huge advantages for hospitals and clinicians, as well as patients, who can be alerted to a need for treatment immediately. Profusa have recently received approval for their first product to measure blood stats in respiratory disease. You can find out more at http://profusa.com/

videos giant health 2016
TOP

We'd love to work with you

Contact Us
London

16-17 Little Portland Street
London
W1W 8BP

+44 (0)20 7291 5070
email

Singapore

8 Cross Street, Level 28
PWC Building
Singapore, 048424

+44 (0)20 7291 5070
email

Suffolk Coast

Basepoint Unit 12a
The Havens
Ransomes Euro Park
Ipswich, IP3 9BF

T. +44 (0)1473 722 794
email

Call Us